A newly defined risk signature, consisting of three m6A RNA methylation regulators, predicts the prognosis of ovarian cancer
Lili Fan, Ying Lin, Han Lei, Guang Shu, Liuer He, Zhipeng Yan, Rihan Hai, Gang Yin
Abstract
A RNA methylation regulators are vital participants in ovarian cancer pathology; and IGF2BP1, VIRMA, and ZC3H13 mRNA levels are valuable factors for prognosis prediction and treatment strategy development.
Topics & Concepts
RNA methylationBiologyOvarian cancerMethylationCancer researchRNAmicroRNACancerGeneGeneticsMethyltransferaseRNA modifications and cancerCancer-related molecular mechanisms researchEpigenetics and DNA Methylation